The Vilsmeier reagent is necessary for producing a large range of pharmaceuticals, but its unstable nature and toxic precursor phosgene are challenges for its use. A new process that efficiently produces phosgene, the Vilsmeier reagent and the desired products in one flow is poised to make the industry greener and safer.
Source:
phys.org